The Lancet· 2014· Review
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
- 2,736citations
- 2014year
Short summary
Alteplase improves good stroke outcomes within 4.5 hours, with benefits decreasing with treatment delay; earlier treatment (within 3 hours) yielded a 32.9% good outcome rate vs. 23.1% for controls (OR 1.75).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Epidemiology
EpidemiologyMedicine